BeStock  
Stocks › Biotechnology › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2344Biotechnology
$29.96 −$1.48 (-4.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $29.96 0.00%
Open$31.12
Prev close$31.44
Day range$29.87 – $31.75
Volume1.75M
Market cap$3.40B
P/E (TTM)–
Dividend yield–

VRDN Stock News

Headlines matching Viridian Therapeutics or the VRDN ticker, most recent first.

  • RBC Capital Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $38 PositiveMarket news · 22 Sep 2026 · Direct mention
  • Truist Financial Maintains Viridian Therapeutics(VRDN.US) With Buy RatingMarket news · 1 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $41Market news · 7 Aug 2026 · Direct mention
  • Truist Financial Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $39 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Wedbush Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $43Market news · 5 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $40 PositiveMarket news · 20 Aug 2026 · Direct mention
  • Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $40Market news · 14 Aug 2026 · Direct mention
  • Truist Financial Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $39Market news · 13 Aug 2026 · Direct mention
  • Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $26Market news · 10 Aug 2026 · Direct mention
  • Wells Fargo Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $31Market news · 20 Jul 2026 · Direct mention
  • Stifel Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $40 PositiveMarket news · 1 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $43Market news · 30 Jun 2026 · Direct mention
  • Jefferies Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $30 PositiveMarket news · 30 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Fortrea Holdings Inc. (FTRE)TipRanks · 29 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $35Market news · 29 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on VRDN.

Sign in to join the discussion.

Scroll to Top